Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related TEVA
Analyst: Mylan Shareholders Might Get Convinced By Vigodman Letter
Teva Beats Q1 Estimates, Raises Full-Year Forecast
M&A Fever Grips Drugmakers (Investor's Business Daily)
Related JASO
Have Short Sellers Given Up On Solar Stocks?
Credit Suisse Expects Strong Growth In 2015 For JA Solar
SunPower Misses Q1 Earnings Estimates on Weak Revenues - Analyst Blog (Zacks)

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Apr 2015Standpoint ResearchUpgradesHoldBuy
Apr 2015Argus ResearchMaintainsBuy
Apr 2015BMO CapitalDowngradesOutperformMarket Perform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (INDB + JASO)

Around the Web, We're Loving...